Sialidases as regulators of bioengineered cellular surfaces

Glycobiology

Volumn 25, Issue 7, 2014, Pages 784-791

  Zamora, Cristina Y ^a,d   Ryan, Matthew J ^a   D'Alarcao, Marc ^b   Kumar, Krishna ^a,c  

^a TUFTS UNIVERSITY   (United States)

^b SAN JOSE STATE UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

4 methylumbelliferyl; metabolic glycoengineering; neuraminidase; sialic acid; sialidase

Indexed keywords

CARBOHYDRATE; GLYCAN; MANNOSAMINE; NEURAMINIC ACID; SIALIC ACID DERIVATIVE; SIALIDASE; GLYCOSIDE; HEXOSAMINE;

ARTICLE; CELL ENGINEERING; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; FLUORINATION; GLYCOCALYX; HUMAN; HUMAN CELL; HYDROPHOBICITY; JURKAT CELL LINE; METABOLIC ENGINEERING; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; BIOENGINEERING; CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM;

MAMMALIA;

BIOENGINEERING; CELL LINE; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSIDES; HEXOSAMINES; HUMANS; JURKAT CELLS; NEURAMINIDASE;

EID: 84936755815     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwv019     Document Type: Article

References (47)

1. Abdulkhalek S, Amith SR, Franchuk SL, Jayanth P, Guo M, Finlay T, Gilmour A, Guzzo C, Gee K, Beyaert R, et al. 2011. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for toll-like receptor activation and cellular signaling. J Biol Chem. 286:36532-36549.
2. Almaraz RT,MathewMP, Tan E, Yarema KJ. 2012. Metabolic oligosaccharide engineering: Implications for selectin-mediated adhesion and leukocyte extravasation. Ann Biomed Eng. 40:806-815.
3. Bondi A. 1964. van der Waals volumes and radii. J Phys Chem. 68:441-451.
4. Brewer CF, Miceli MC, Baum LG. 2002. Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol. 12:616-623.
5. Campbell CT, Sampathkumar S-G, Yarema KJ. 2007. Metabolic oligosaccharide engineering: Perspectives, applications, and future directions. Mol BioSyst. 3:187.
6. Chang PV, Chen X, Smyrniotis C, Xenakis A, Hu T, Bertozzi CR, Wu P. 2009. Metabolic labeling of sialic acids in living animals with alkynyl sugars. Angew Chem Int Ed. 48:4030-4033.
7. Chen X, Varki A. 2010. Advances in the Biology and Chemistry of Sialic Acids. ACS Chem Biol. 5:163-176.
8. Dafik L, d'Alarcao M, Kumar K. 2008. Fluorination of mammalian cell surfaces via the sialic acid biosynthetic pathway. Bioorg Med Chem Lett. 18:5945-5947.
9. Dafik L, d'Alarcao M, Kumar K. 2010. Modulation of cellular adhesion by glycoengineering. J Med Chem. 53:4277-4284.
10. DeMarco ML,Woods RJ. 2008. Structural glycobiology: a game of snakes and ladders. Glycobiology. 18:426-440.
11. Du J, Meledeo MA, Wang Z, Khanna HS, Paruchuri VDP, Yarema KJ. 2009. Metabolic glycoengineering: Sialic acid and beyond. Glycobiology. 19:1382-1401.
12. Du J, Yarema KJ. 2010. Carbohydrate engineered cells for regenerative medicine. Adv Drug Deliv Rev. 62:671-682.
13. Dube D. 2003. Metabolic oligosaccharide engineering as a tool for glycobiology. Curr Opin Chem Biol. 7:616-625.
14. Gadhoum SZ, Sackstein R. 2008. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat Chem Biol. 4:751-757.
15. Grant OC, SmithHM, Firsova D, Fadda E,Woods RJ. 2013. Presentation, presentation, presentation! Molecular-level insight into linker effects on glycan array screening data. Glycobiology. 24:17-25.
16. Hara S, Yamaguchi M, Takemori Y, Nakamura M, Ohkura Y. 1986. Highly sensitive determination of N-acetyl-and N-glycolylneuraminic acids in human serum and urine and rat serum by reversed-phase liquid chromatography with fluorescence detection. J Chromatogr. 377:111-119.
17. Hsu TL, Hanson SR, Kishikawa K,Wang SK, Sawa M,Wong CH. 2007. Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc Natl Acad Sci USA. 104:2614-2619.
18. Ishii A, Ohta M,Watanabe Y, Matsuda K, Ishiyama K, Sakoe K, NakamuraM, Inokuchi JI, Sanai Y, Saito M. 1998. Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase. J Biol Chem. 273:31652-31655.
19. Kakugawa Y,Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T. 2002. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA. 99:10718-10723.
20. KepplerOT, Hinderlich S, Langner J, Schwartz-Albiez R, ReutterW, Pawlita M. 1999. UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation. Science. 284:1372-1376.
21. Khedri Z, Li Y, Cao H, Qu J, Yu H, Muthana MM, Chen X. 2012. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2. Org Biomol Chem. 10:6112-6120.
22. Li Y, Cao H, Yu H, Chen Y, Lau K, Qu J, Thon V, Sugiarto G, Chen X. 2011. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies. Mol BioSyst. 7:1060.
23. Magesh S, Suzuki T, Miyagi T, Ishida H, Kiso M. 2006. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: Hints for the design of selective NEU3 inhibitors. J Mol Graph Modell. 25:196-207.
24. Miyagi T, Wada T, Yamaguchi K, Hata K. 2004. Sialidase and malignancy: A minireview. Glycoconj J. 20:189-198.
25. Miyagi T, Yamaguchi K. 2012. Mammalian sialidases: Physiological and pathological roles in cellular functions. Glycobiology. 22:880-896.
26. Parker RB, Kohler JJ. 2010. Regulation of intracellular signaling by extracellular glycan remodeling. ACS Chem Biol. 5:35-46.
27. Patel PD, Yan P, Seidler PM, Patel HJ, Sun W, Yang C, Que NS, Taldone T, Finotti P, Stephani RA, et al. 2013. Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2. Nat Chem Biol. 9:677-684.
28. Petsalakis EI, Chrysina ED, Tiraidis C, Hadjiloi T, Leonidas DD, Oikonomakos NG, Aich U, Varghese B, Loganathan D. 2006. Crystallographic studies on N-azidoacetyl-beta-D-glucopyranosylamine, an inhibitor of glycogen phosphorylase: Comparison with N-acetyl-beta-Dglucopyranosylamine. Bioorg Med Chem. 14:5316-5324.
29. Pshezhetsky AV, Hinek A. 2011. Where catabolism meets signalling: Neuraminidase 1 as a modulator of cell receptors. Glycoconj J. 28:441-452.
30. Pshezhetsky AV, Richard C, Michaud L, Igdoura S,Wang S, Elsliger MA, Qu J, Leclerc D, Gravel R, Dallaire L, et al. 1997. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet. 15:316-320.
31. Sandbhor MS, Soya N, Albohy A, Zheng RB, Cartmell J, Bundle DR, Klassen JS, Cairo CW. 2011. Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone. Biochemistry. 50:6753-6762.
32. Saxon E, Bertozzi CR. 2000. Cell surface engineering by a modified Staudinger reaction. Science. 287:2007-2010.
33. Shiozaki K, Yamaguchi K, Takahashi K, Moriya S, Miyagi T. 2011. Regulation of sialyl Lewis antigen expression in colon cancer cells by sialidase NEU4. J Biol Chem. 286:21052-21061.
34. Shkandina T, Herrmann M, Bilyy R. 2012. Sweet kiss of dying cell: Sialidase activity on apoptotic cell is able to act toward its neighbors. Autoimmunity. 45:574-578.
35. Smutova V, Albohy A, Pan X, Korchagina E, Miyagi T, Bovin N, Cairo CW, Pshezhetsky AV. 2014. Structural basis for substrate specificity of Mammalian neuraminidases. PLoS ONE. 9:e106320.
36. Tan E, Almaraz RT, Khanna HS, Du J, Yarema KJ. 2010. Experimental design considerations for in vitro non-natural glycan display via metabolic oligosaccharide engineering. Curr Protoc Chem Biol. 2:171-194.
37. Tanaka Y, Kohler JJ. 2008. Photoactivatable crosslinking sugars for capturing glycoprotein interactions. J Am Chem Soc. 130:3278-3279.
38. Tessier MB, Grant OC, Heimburg-Molinaro J, Smith D, Jadey S, Gulick AM, Glushka J, Deutscher SL, Rittenhouse-Olson K, Woods RJ. 2013. Computational screening of the human TF-glycome provides a structural definition for the specificity of anti-tumor antibody JAA-F11. PLoS ONE. 8:e54874.
39. Tringali C, Lupo B, Anastasia L, Papini N, Monti E, Bresciani R, Tettamanti G, Venerando B. 2007. Expression of sialidase Neu2 in leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signaling. J Biol Chem. 282:14364-14372.
40. Uhlig N, Li C-J. 2011. Alkynes as an eco-compatible "on-call" functionality orthogonal to biological conditions in water. Chem Sci. 2:1241-1249.
41. Wang L, Cummings RD, Smith DF, Huflejt M, Campbell CT, Gildersleeve JC, Gerlach JQ, Kilcoyne M, Joshi L, Serna S, et al. 2014. Cross-platform comparison of glycan microarray formats. Glycobiology. 24:507-517.
42. Whitman CM, Yang F, Kohler JJ. 2011. Modified GM3 gangliosides produced by metabolic oligosaccharide engineering. Bioorg Med Chem Lett. 21:1-5.
43. Wright L, Barril X, Dymock B, Sheridan L, Surgenor A, Beswick M, Drysdale M, Collier A, Massey A, Davies N, et al. 2004. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem Biol. 11:775-785.
44. Yarema KJ, Mahal LK, Bruehl RE, Rodriguez EC, Bertozzi CR. 1998. Metabolic delivery of ketone groups to sialic acid residues. J. Biol. Chem. 273:31168.
45. Yoder NC, Yüksel D, Dafik L, Kumar K. 2006. Bioorthogonal noncovalent chemistry: Fluorous phases in chemical biology. Curr Opin Chem Biol. 10:576-583.
46. Zamora CY, Dafik L, Kumar K. 2012. Chemical biology using fluorinated building blocks. In: Gale PA, Steed JW, editors. Supramolecular Chemistry: From Molecules to Nanomaterials. Chichester (UK): John Wiley & Sons. p. 1947-1964.
47. Zamora CY, d'Alarcao M, Kumar K. 2013. Fluorogenic sialic acid glycosides for quantification of sialidase activity upon unnatural substrates. Bioorg Med Chem Lett. 23:3406-3410.